Twitter (TWTR) CEO to Step Down - Reuters
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
Twitter (TWTR) Resumes Trading Following Halt
November 29, 2021 10:57 AM ESTTwitter (NYSE: TWTR) Resumes Trading Following Halt
... MoreTwitter (TWTR) Halted, News Pending
November 29, 2021 9:53 AM ESTTwitter (NYSE: TWTR) Halted, News Pending
... MoreTwitter (TWTR) Stock Soars 9% on Report CEO Jack Dorsey to Step Down, Square (SQ) Up 3%
November 29, 2021 9:33 AM ESTShares of Twitter (NYSE: TWTR) are up 9% Monday after CNBC reported that CEO Jack Dorsey is expected to step down from his executive role.
Dorsey, who also acts as CEO of Square (NYSE: SQ), co-founded... More
Pre-Open Stock Movers 11/29: (KRYS) (ADGI) (TWTR) Higher; (MRK) (UPS) Lower (more...)
November 29, 2021 9:30 AM ESTPre-Open Stock Movers:
Krystal Biotech, Inc., (NASDAQ: KRYS) 142.6% HIGHER; announced positive topline results from the pivotal GEM-3 trial of investigational beremagene geperpavec (B-VEC), now known as VYJUVEKTM, for the treatment of dystrophic Epidermolysis Bullosa (dystrophic EB). The primary endpoint of the trial evaluated complete wound healing of topical VYJUVEKTM compared to placebo at six-month timepoints and met statistical significance. VYJUVEKTM is the first non-invasive, topical and redosable gene therapy in development, and the only genetically corrective... More
Twitter (TWTR) option IV flat into Dorsey expected to step down as Twitter CEO, CNBC's Faber says
November 29, 2021 9:25 AM ESTTwitter (NYSE: TWTR) 30-day option implied volatility is at 45; compared to its 52-week range of 32 to 91 into Jack Dorsey expected to step down as Twitter CEO, CNBC's Faber says.
... MoreSquare (SQ) gains 3.5% on news Jack Dorsey to step down as CEO of Twitter
November 29, 2021 9:24 AM ESTSquare (NYSE: SQ) gains 3.5% on news Jack Dorsey to step down as CEO of Twitter (NYSE: TWTR). He is also CEO of SQ.
... MoreTwitter (TWTR) shares gain 9% on news CEO Jack Dorsey planning to step down
November 29, 2021 9:21 AM ESTTwitter (NYSE: TWTR) shares gain 9% on news CEO Jack Dorsey planning to step down.
... MoreTwitter (TWTR) CEO Jack Dorsey to Step Down - CNBC
November 29, 2021 9:20 AM EST(Updated - November 29, 2021 9:22 AM EST)
Twitter (NYSE: TWTR) CEO Jack Dorsey is expected to step down in the near term, according to a report from CNBC's David Faber.
Dorsey is also the CEO of Square (NYSE: SQ).
... More